Alkem Laboratories Limited ALKEM.NS · Stock Open Alkem Laboratories Limited in new tab
Alkem Laboratories Limited Analysis (ALKEM.NS)
Is Alkem Laboratories Limited a good investment? Alkem Laboratories Limited (ALKEM.NS) is currently trading at 5608.00 INR. Market analysts have a consensus price target of 5964.80 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 29.49. This valuation is generally in line with the broader market.
Earnings Schedule: Alkem Laboratories Limited is expected to release its next earnings report on Aug. 7, 2026. The market consensus estimate for Forward EPS is 226.20.
For income investors, Alkem Laboratories Limited pays a dividend yield of 0.88%. With a payout ratio of 4%, the dividend appears sustainable.
Investor FAQ
Does Alkem Laboratories Limited pay a dividend?
Yes, it pays an annual dividend of 51.00 INR (0.88% yield).
What asset class is Alkem Laboratories Limited?
Alkem Laboratories Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 7, 2026. The company currently has a trailing EPS of 192.68.
Company Profile
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers biosimilars, active pharmaceutical ingredients, branded and trade generics, complex generics, and consumer wellness products in therapeutic areas comprising anti infective, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory, rheumatology, central nervous system, anti-diabetic, iron deficiency, pain management, and urology, as well as vitamins, minerals, and nutrients. It also provides cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. Alkem Laboratories Limited was incorporated in 1973 and is based in Mumbai, India.
| Year | Total Dividends |
|---|---|
| ▸2027 |
48.86 INR
|
| March 8, 2027 (estimated) | 48.8555 |
| ▸2026 |
53.00 INR
|
| Sept. 1, 2026 | 10.0000 |
| March 6, 2026 | 43.0000 |
| ▸2025 |
45.00 INR
|
| Sept. 24, 2025 | 8.0000 |
| Feb. 28, 2025 | 37.0000 |
| ▸2024 |
40.00 INR
|
| Sept. 4, 2024 | 5.0000 |
| March 1, 2024 | 35.0000 |
| ▸2023 |
50.00 INR
|
| Aug. 30, 2023 | 10.0000 |
| March 1, 2023 | 40.0000 |
| ▸2022 |
34.00 INR
|
| Sept. 24, 2022 | 4.0000 |
| March 6, 2022 | 30.0000 |
| ▸2021 |
30.00 INR
|
| Sept. 19, 2021 | 5.0000 |
| March 7, 2021 | 25.0000 |
| ▸2020 |
25.00 INR
|
| Sept. 17, 2020 | 3.0000 |
| March 8, 2020 | 22.0000 |
| ▸2019 |
16.00 INR
|
| Sept. 26, 2019 | 8.0000 |
| March 10, 2019 | 8.0000 |
| ▸2018 |
13.00 INR
|
| Sept. 30, 2018 | 7.0000 |
| March 11, 2018 | 6.0000 |
| ▸2017 |
9.00 INR
|
| Oct. 1, 2017 | 9.0000 |
| ▸2016 |
15.70 INR
|
| Nov. 28, 2016 | 6.0000 |
| July 1, 2016 | 9.7000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Alkem Laboratories Limited | Sep 01, 2026 | Upcoming | 10.0 INR |
| Alkem Laboratories Limited | Mar 06, 2026 | Paid | 43.0 INR |
| Alkem Laboratories Limited | Sep 24, 2025 | Paid | 8.0 INR |
Community Discussion